Call for head of stem cell institute to resign
By San Francisco Chronicle,
San Francisco Chronicle
| 01. 19. 2006
An East Bay biotechnology watchdog group on Wednesday called for the resignation of Robert Klein, chairman of the Proposition 71 stem cell agency known as the California Institute for Regenerative Medicine.
Jesse Reynolds, stem cell specialist at the group, the Center for Genetics and Society, said the Prop. 71 enterprise needs a fresh start after a year in business, even though the institute has been mired in litigation that has blocked its ability to distribute grant money into stem cell research.
Klein said through a spokeswoman that he intended to stay.
The Oakland advocacy group gave the California Institute for Regenerative Medicine an overall grade of "C-minus" in a 32-page report examining how Prop. 71 has been implemented. Most of the critique covered familiar complaints about inadequate governance and the need for more health protections for women who may be recruited as stem cell research subjects.
Klein, a Stanford-educated lawyer and real estate developer, drafted the proposition and led the 2004 election campaign after he became convinced that California needed to advance stem cell research to cure common diseases. Prop...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...